Francesc Bosch
Oncology
Vall d'Hebron Institut d’Oncologia
Spain
Biography
Dr. Francesc Bosch is currently working as a Principal Investigator of VHIO´s Experimental Hematology Group in the Department of Oncology, Vall d'Hebron Institute of Oncology , Spain. His research interests includes Biological and clinical studies in hematological malignancies. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Francesc Bosch is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Biological and clinical studies in hematological malignancies.
Research Interest
Biological and clinical studies in hematological malignancies.
Publications
-
Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, Salido M, Gallen M, Marsters S, Tsai SP, Minoche A, Somasekar S, Serrano S, Himmelbauer H, Bellmunt J, Rovira A, Settleman J, Bosch F, Albanell J. Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer. Nat Med. 2012 Jan 22;18(2):221-3
-
Bosch F, Abrisqueta P, Villamor N, Terol MJ, González-Barca E, Ferra C, González Diaz M, Abella E, Delgado J, Carbonell F, GarcÃa Marco JA, Escoda L, Ferrer S, Monzó E, González Y, Estany C, Jarque I, Salamero O, Muntañola A, Montserrat E. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia. J Clin Oncol. 2009 Sep 20;27(27):4578-84.
-
Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé BS, López-Guillermo A, Campo E, Monserrat E. ZAP-70 expression as a surrogate for immunoglobulin variable region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764-75.
